Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Biotech
Novartis pays SciNeuro $165M for ticket on brain shuttle
Novartis’ continuing search for new ways to take drugs into the brain has resulted in a $1.7 billion deal with SciNeuro Pharmaceuticals.
James Waldron
Jan 12, 2026 8:49am
Voyager jettisons staff, Novartis hands back 2 programs
Dec 17, 2025 4:50pm
ASH: Novartis details ianalumab's phase 3 rare blood disease win
Dec 9, 2025 7:30am
Novartis pens $1.7B atopic disease pact with British biotech
Dec 9, 2025 3:57am
Why Novartis CEO was willing to pay top dollar for Avidity
Nov 20, 2025 4:37am
Novartis' resistance-busting malaria drug hits phase 3 goal
Nov 13, 2025 7:05am
